Results 271 to 280 of about 5,297,540 (313)

Progress in surgical management strategies after neoadjuvant therapy in breast cancer. [PDF]

Ann Med
Zhu R, Kong L, Sun S.
europepmc   +1 more source

The impact of circWWC3 on neoadjuvant therapy for triple-negative breast cancer and the construction of a nomogram for predicting pathological complete response after neoadjuvant therapy. [PDF]

Front Oncol
Wang H, Liu H, Gao S, Wang L, Bai Z, Zhang Y, Zhang P, Liu F, Geng C.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tislelizumab combined with chemotherapy as neoadjuvant therapy for surgically resectable esophageal cancer: A prospective, single-arm, phase II study (TD-NICE).

International Journal of Surgery, 2022
BACKGROUND Clinical benefit of neoadjuvant immunotherapy in resectable esophageal squamous cell carcinoma (ESCC). remains unclear. This study evaluated the efficacy and safety of the programmed death 1 (PD-1) inhibitor tislelizumab combined with ...
Xiaolong Yan, Hongtao Duan, Yun-feng Ni, Yong’an Zhou, Xiaoping Wang, Haini Qi, L. Gong, Honggang Liu, F. Tian, Q. Lu, Jianyong Sun, E. Yang, D. Zhong, Tao Wang, Lijun Huang, Jian Wang, chaoyang Wang, Yuanyong Wang, Zhiyi Wan, J. Lei, Jinbo Zhao, T. Jiang   +21 more
semanticscholar   +1 more source

Breast MRI for Evaluation of Response to Neoadjuvant Therapy.

Radiographics, 2021
Neoadjuvant therapy is increasingly being used to treat early-stage triple-negative and human epidermal growth factor 2-overexpressing breast cancers, as well as locally advanced and inflammatory breast cancers. The rationales for neoadjuvant therapy are
B. Reig, Alana A. Lewin, Linda Du, L. Heacock, H. Toth, S. Heller, Yiming Gao, L. Moy   +7 more
semanticscholar   +1 more source

Revisiting neoadjuvant therapy in non-small-cell lung cancer.

The Lancet Oncology, 2021
Despite the rapidly evolving treatment landscape in advanced non-small-cell lung cancer (NSCLC), developments in neoadjuvant and adjuvant treatments have been nascent by comparison.
S. Saw, B. Ong, K. Chua, A. Takano, D. S. Tan   +4 more
semanticscholar   +1 more source